Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Britain's Great Life Sciences Future Genomics, Personalised Medicine and AI Ping Virtual Conference 2020

Thursday, 26 November 2020, 9am to 5pm

VWV are delighted to bring you the first-ever virtual 2020 PING Conference, focused on ‘Britain’s Great Life Sciences Future – Genomics, Personalised Medicine and AI’.

This image is advertising BRITAIN'S GREAT LIFE SCIENCES FUTURE GENOMICS, PERSONALISED MEDICINE AND AI PING VIRTUAL CONFERENCE 2020

This one full-day virtual conference includes:

  • An engaging, interactive programme with a high calibre of inspirational keynote speakers and presentations on key topics affecting the pharmaceuticals and life sciences industry
  • High-quality panel discussions and breakout sessions with individual speakers
  • Networking opportunities with other attendees

 

WHO WILL BE SPEAKiNG?

  • Parker Moss – Chief Commercial and Partnership Officer, Genomics England
  • Joanne Hackett – Chair, Pexxi and formerly Chief Commercial Officer, Genomics England
  • Matthew Durdy – Chief Business Officer, Cell and Gene Therapy Catapult
  • Karen Taylor and John Haughey – Head of Centre for Health Solutions and Global Life Sciences Consulting Leader, Deloitte
  • Jackie Hunter – Board Director, Benevolent AI
  • Nick Lench – Chief Scientific Officer, Congenica
  • John McKinley – Executive Board Director, Avesthagen
  • Yogesh Davé – Director, Cypress Quality Consultancy

 

For more information and to register, click here